Your session is about to expire
← Back to Search
Other
Caloric Vestibular Stimulation for OCD
N/A
Recruiting
Led By Peter J van Roessel, MD, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 days
Treatment Varies
Follow Up 3 days
Awards & highlights
No Placebo-Only Group
Summary
This trial investigates if using warm or cold water in the ear can help people with obsessive-compulsive disorders better understand their condition by stimulating certain brain areas.
Who is the study for?
This trial is for adults aged 18-65 with a primary diagnosis of Obsessive-Compulsive Disorder, Body Dysmorphic Disorder, Illness Anxiety Disorder, or Somatic Symptom Disorder. Participants should not have had recent changes in any psychopharmacological treatment and must be able to provide informed consent. Pregnant or nursing women, individuals with substance use issues or certain medical conditions like vertigo are excluded.
What is being tested?
The study is testing caloric vestibular stimulation—a procedure that involves stimulating the balance organs in the ears using temperature—to see if it can change how people with obsessive-compulsive spectrum disorders perceive their symptoms.
What are the potential side effects?
Caloric vestibular stimulation may cause temporary discomfort such as dizziness, nausea, or imbalance due to its effect on the inner ear's balance mechanisms.
Timeline
Screening ~ 3 days1 visit
Treatment ~ Varies
Follow Up ~ 3 days1 visit
Screening ~ 3 days
Treatment ~ Varies
Follow Up ~3 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
change in clinical insight as measured by the Brown Assessment of Beliefs (BABS).
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: right cold caloric vestibular stimulationExperimental Treatment1 Intervention
OCRD participants in this arm will receive an approx 60 second infusion of distilled cold(4)c water in their right external ear canal, with before and after measures of OCRD symptom severity and insight.
Group II: left cold caloric vestibular stimulationExperimental Treatment1 Intervention
OCRD participants in this arm will receive an approx 60 second infusion of distilled cold(4)c water in their left external ear canal, with before and after measures of OCRD symptom severity and insight.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for Obsessive-Compulsive Disorder (OCD) include selective serotonin reuptake inhibitors (SSRIs), deep brain stimulation (DBS), and cognitive-behavioral therapy (CBT). SSRIs work by increasing serotonin levels in the brain, which helps reduce OCD symptoms by improving mood and anxiety regulation.
DBS involves implanting electrodes in specific brain areas to modulate neural circuits implicated in OCD, offering relief for treatment-resistant cases. CBT, particularly exposure and response prevention, helps patients confront and reduce compulsive behaviors through structured therapeutic techniques.
These treatments are crucial as they target the underlying neurobiological and psychological mechanisms of OCD, providing symptom relief and improving quality of life. Caloric Vestibular Stimulation, which involves stimulating the vestibular system to modulate cognitive and emotional processes, represents a novel approach that could complement existing therapies by potentially influencing brain regions involved in OCD.
Vestibulo-ocular reflex.Advances in pharmacotherapy of vestibular and ocular motor disorders.Animal models of obsessive compulsive disorder: recent findings and future directions.
Vestibulo-ocular reflex.Advances in pharmacotherapy of vestibular and ocular motor disorders.Animal models of obsessive compulsive disorder: recent findings and future directions.
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,491 Previous Clinical Trials
17,519,196 Total Patients Enrolled
16 Trials studying Obsessive-Compulsive Disorder
1,394 Patients Enrolled for Obsessive-Compulsive Disorder
Peter J van Roessel, MD, PhDPrincipal InvestigatorStanford University
1 Previous Clinical Trials
45 Total Patients Enrolled
1 Trials studying Obsessive-Compulsive Disorder
45 Patients Enrolled for Obsessive-Compulsive Disorder
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have been diagnosed with certain mental health disorders, including Obsessive-Compulsive Disorder, Body Dysmorphic Disorder, Illness Anxiety Disorder, or Somatic Symptom Disorder (excluding "with predominant pain").You are currently pregnant or breastfeeding.You are currently using or have recently used drugs or alcohol.You have strong worries related to Obsessive-Compulsive and Related Disorders (OCRD) that meet the BABS score criterion.You have a medical or psychiatric condition, such as vertigo or a history of ear surgery, that could make it unsafe for you to take part in the study.
Research Study Groups:
This trial has the following groups:- Group 1: left cold caloric vestibular stimulation
- Group 2: right cold caloric vestibular stimulation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: You will receive the treatment for 3 null
- Follow Ups: You may be asked to continue sharing information regarding the trial for 3 Months after you stop receiving the treatment.
Obsessive-Compulsive Disorder Patient Testimony for trial: Trial Name: NCT03918577 — N/A